Figure (IMAGE)
Caption
68Ga-PSMA11 PET MIP images at baseline and after 2 cycles of 177Lu-PSMA radioligand therapy in a patients with mCRPC.
Credit
Andrei Gafita, Matthias Eiber, TUM School of Medicine, Klinikum rechts der Isar, Munich, Germany.
Usage Restrictions
None
License
Licensed content